本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Monopar Therapeutics

39.59
+1.574.13%
盘后39.590.00000.00%16:05 EDT
成交量:1.16万
成交额:45.73万
市值:2.42亿
市盈率:-9.63
高:40.12
开:39.45
低:38.75
收:38.02
数据加载中...
2019/11/04

[修订]招股说明书

[Amend] General form for registration of securities under the Securities Act of 1933
2019/11/04

[修订]招股说明书

[Amend] General form for registration of securities under the Securities Act of 1933
2019/10/02

SEC问询函

[Cover]Correspondence
2019/10/02

SEC问询函

[Cover]Correspondence
2019/10/01

[修订]招股说明书

[Amend] General form for registration of securities under the Securities Act of 1933
2019/09/30

SEC问询函

[Cover]Correspondence
2019/09/23

[补充]招股说明书

Filing under Securities Act Rules 163/433 of free writing prospectuses
2019/09/13

[修订]招股说明书

[Amend] General form for registration of securities under the Securities Act of 1933
2019/09/10

[修订]招股说明书

[Amend] General form for registration of securities under the Securities Act of 1933
2019/08/15

招股说明书

General form for registration of securities under the Securities Act of 1933
2019/08/08

季度报告

Quarterly report [Sections 13 or 15(d)]
2019/06/27

重要事件披露

Current report, item 5.07
2019/05/10

季度报告

Quarterly report [Sections 13 or 15(d)]
2019/02/26

年度报告

Annual report [Section 13 and 15(d), not S-K Item 405]
2018/12/11

SEC问询函

[Cover]Correspondence
2018/12/11

[修订]年度报告

[Amend] Annual report [Section 13 and 15(d), not S-K Item 405]
2018/12/11

[修订]季度报告

[Amend] Quarterly report [Sections 13 or 15(d)]
2018/12/11

[修订]季度报告

[Amend] Quarterly report [Sections 13 or 15(d)]
2018/12/11

[修订]季度报告

[Amend] Quarterly report [Sections 13 or 15(d)]
2018/11/09

季度报告

Quarterly report [Sections 13 or 15(d)]